Commercial Space Company Risk / Opportunity Ranking

Thesis: The reviewed sources indicates Kratos has space-defense relevance, including a stated U.S. Space Force/Space Systems Command contract in membership rationale, but there are no retained direct evidence or article summaries within the 90-day recent evidence window to support a current 1 year+ opportunity thesis.

Why now: Why now is weak because no article summaries or direct evidence were retained after the March 29, 2026 cutoff; recency is therefore insufficiently supported in these reviewed sources.

Caveats: Membership rationale references support references and, but no article or retained evidence are provided, so they cannot be cited as factual support under the output rules. Coverage debug shows articles after recent evidence window 0 and evidence after recent evidence window 0.

Thesis: No direct positive evidence is retained in the reviewed sources for KVH Industries within the selected recent evidence window.

Why now: The membership rationale says KVH appeared as a listed player in a generic defense satellite communication market report tied to article: but the reviewed sources retains zero evidence after recent evidence window and provides no, so this is too weak for a directional thesis.

Caveats: Generic market-report mention is weaker than company-specific event evidence. The support article ID is cited in the reviewed sources rationale but no article or retained evidence row is provided.

Thesis: The membership rationale indicates LandSpace is a Chinese commercial rocket company pursuing IPO funding and reusable rocket development, but the reviewed sources includes no available within the recent evidence window evidence or article summaries that can support a directional opportunity thesis in this screen.

Why now: Why-now is weak because no within the recent evidence window evidence are available, so timing, financing status, and launch progress cannot be judged from the current reviewed sources.

Caveats: Membership rationale references, and, but no article details are available here. Coverage debug shows articles after recent evidence window 0 and evidence after recent evidence window 0. Potential IPO/funding relevance is mentioned only in membership rationale and cannot be elevated without direct evidence.

Thesis: No direct positive evidence is available in the reviewed sources, so no opportunity thesis is supportable.

Why now: The reviewed sources only describes that Intuitive Machines acquired Lanteris for about $800M via article, but provides no available evidence, no business description, and no.

Caveats: Acquisition mention without business detail is insufficient for ranking direction. No post-recent evidence window evidence are available. Referenced has no in the reviewed sources.

Thesis: Reviewed evidence rationale suggests Lonestar is a space data storage startup with a NASA Space Act Agreement and orbital/lunar storage infrastructure, but there is no retained direct positive evidence with article inside the 90-day recent evidence window, so a positive thesis is not currently supportable.

Why now: Why now is weak because 8 articles were considered but zero remained after the March 29, 2026 cutoff, leaving no current catalyst or status confirmation.

Caveats: No recent evidence window-qualified evidence. Phase-2 rationale is not enough for directional conviction.

Thesis: Insufficient retained evidence within the reviewed sources to support a positive 1 year+ opportunity thesis.

Why now: There is no available post-recent evidence window evidence for this company. The reviewed sources notes two considered articles, but zero article IDs after recent evidence window and zero evidence retained, so recency-sensitive judgment is not possible.

Caveats: The reviewed sources say support used article IDs existed earlier, but no retained evidence are available after the 90-day recent evidence window cutoff of March 29, 2026. Absence of evidence is not positive or negative proof.

Thesis: There is a possible long-horizon opportunity if LSS is indeed participating as part of an HPS/LSS consortium building a deployable antenna reflector for a GEO telecommunications satellite, but the reviewed sources provide no available direct evidence inside the 90-day recent evidence window to validate scale, timing, or economics.

Why now: There is no clear 'now' catalyst in the available evidence. The reviewed sources states zero article IDs after recent evidence window and zero evidence available after recent evidence window, so recency is unverified for a 1 year+ ranking.

Caveats: Phase-2 rationale references consortium work tied to: and: but the reviewed sources does not include article summaries or for those items. Coverage debug shows zero evidence after recent evidence window, so no direct claim can be validated as current. Cohort review status is not a directional signal.

Thesis: Lumen Orbit is only described as being mentioned among initiatives related to orbital data centers in an article centered on other companies, which is too weak and indirect to support a positive thesis.

Why now: No dated or citable event evidence is available. The reviewed sources indicates provisional single-article context tied to article id: but no or summary is provided and no evidence survived recent evidence window.

Caveats: Support level is explicitly provisional_single_article_context, which is weaker than company-specific event or fact evidence. No current evidence is provided for article: preventing direct citation. Scores remain minimal due to lack of evidence, not a strong negative view.

Thesis: Reviewed evidence rationale says Lunar Outpost won NASA moon-base or lunar terrain vehicle related work, but no retained article/evidence are available here to substantiate an investable opportunity view.

Why now: There is no retained post-recent evidence window evidence row in these reviewed sources despite membership rationale referencing NASA-related wins, so timing support is insufficient.

Caveats: Membership rationale is not enough for a strong thesis without cited retained evidence. Coverage after recent evidence window is effectively zero in these reviewed sources.

Thesis: Only minimal historical profile-style support is noted for Lunar Outpost as a private company focused on space robotics and lunar surface mobility, but no direct positive evidence survived the 90-day recent evidence window, so there is not enough local evidence to support a substantive 1 year+ opportunity thesis.

Why now: No within the recent evidence window company-specific catalyst or business-state change is available. Coverage debug shows 0 article IDs after recent evidence window and 0 evidence after recent evidence window, with cutoff date March 29, 2026.

Caveats: Reviewed evidence references only a profile-like article via membership rationale, not available direct evidence: but no is provided in these reviewed sources. No current source-cited evidence was found in the reviewed sources.

Thesis: The reviewed sources places M-tron in a 'public space names' market article, but that is thematic basket context rather than direct proof of company-specific opportunity.

Why now: No direct catalyst or citable business-state evidence is available. The reviewed sources references article ids: and: but provides no and no retained evidence.

Caveats: The reviewed sources explicitly says the evidence is mostly thematic/stock-basket context rather than direct business description. No or quotes are provided for direct citation.

Thesis: No positive thesis is supportable from the retained evidence in these reviewed sources. Phase-2 rationale references a partnership with D-Orbit for an electric propulsion demo tied to article, but no representative article, quote, or retained within the recent evidence window evidence row is available here, so the opportunity case cannot be grounded to reviewed sources-standard evidence.

Why now: Why now is weak because the reviewed sources' evidence recent evidence review shows zero kept rows after the 90-day cutoff ending March 29, 2026 and coverage data shows articles after recent evidence window of 0, so recency is not established from retained evidence.

Caveats: Phase-2 membership rationale cites but no or retained evidence row is provided in these reviewed sources, so it cannot be used for factual claims. Coverage after recent evidence window is effectively empty: evidence recent evidence review cutoff_date March 29, 2026 with kept_rows 0. Scores reflect insufficient evidence, not a fundamental bearish or bullish view.

Thesis: No positive thesis is supportable from retained evidence. Phase-2 rationale notes Manastu Space is listed among Indian new-space startups and mentions 'Manastu Space thrusters' tied to article, but the reviewed sources have no representative article or retained evidence row after recent evidence window.

Why now: Why now is weak because no evidence survived the 90-day recent evidence window in the available reviewed sources; evidence recent evidence review kept_rows is 0 and coverage data articles after recent evidence window is 0.

Caveats: Phase-2 rationale is not enough for a factual claim without and retained evidence detail. No within the recent evidence window direct evidence is available. Low scores reflect absence of usable evidence.

Thesis: The membership rationale suggests launch-readiness relevance, but no retained 90-day direct positive evidence is available to support an opportunity thesis.

Why now: The reviewed sources show zero retained article IDs and zero evidence after recent evidence filtering, so there is no recent company-specific evidence base for a 1 year+ directional call.

Caveats: Historical membership support references article IDs, but no post-recent evidence window evidence are served here. Low scores reflect insufficient evidence, not an evaluated business conclusion.

Thesis: The reviewed sources only mentions Marlan Space as an IHC affiliate and partner in the Orbitworks constellation effort, which is context-only and insufficient for a positive thesis without direct company-specific progress evidence.

Why now: There is no available within the recent evidence window evidence row after the March 29, 2026 cutoff; coverage data shows zero article IDs after recent evidence window and zero evidence after recent evidence window for Marlan Space.

Caveats: Phase-2 membership rationale references article: but the reviewed sources provide no for citation. Partnership context alone should not be treated as propagated operating evidence under the evidence standard.

Thesis: There is insufficient direct evidence in the reviewed sources to support an opportunity thesis beyond generic market-report inclusion as a key player in optical satellite markets.

Why now: No 'why now' is evidenced. The reviewed sources show zero post-recent evidence window available evidence despite a large article universe.

Caveats: Phase-2 rationale references: but no or summary is provided. Generic market-report mention is weaker than direct company event/fact evidence. Coverage debug shows zero evidence after recent evidence window.

Thesis: A weak opportunity case exists only because the phase2 rationale says MizarVision images were referenced in a geopolitical article, implying some satellite-imagery relevance. However, the reviewed sources does not provide direct company-specific operating evidence or a citable article summary/.

Why now: No in-recent evidence window article summary or evidence row is available for MizarVision. The only timing cue is an uncited phase2 rationale referencing article id without.

Caveats: Evidence is indirect and not strongly company-specific according to the reviewed sources rationale. No citable article or summary is provided for the referenced article id. No evidence were available after recent evidence window.

Thesis: No affirmative opportunity thesis is supportable from retained evidence. Phase-2 rationale says Moog is cited in a satellite propulsion market report, but no representative article details or retained evidence row is present in the reviewed sources.

Why now: Why now is weak because the reviewed sources have no within the recent evidence window evidence; evidence recent evidence review kept_rows is 0 and coverage data articles after recent evidence window is 0.

Caveats: The lawsuit reference exists only in phase-2 rationale without or retained evidence detail, so it is too weak for a material risk call. No direct evidence arrays are populated. Score reflects limited unresolved risk context plus very sparse evidence.

Thesis: The reviewed sources rationale says Moog supplies components for NASA SLS and is involved in satellite propulsion and components, but no direct positive evidence with article survives the 90-day recent evidence window, so opportunity support is insufficient.

Why now: Why now is weak because despite 72 articles considered, zero article IDs and zero evidence were retained after the March 29, 2026 cutoff, preventing any current sequencing or catalyst assessment.

Caveats: No admissible post-recent evidence window evidence. Membership review rationale is contextual only and not a directional scoring basis by itself.

Thesis: Membership rationale indicates Moonshot Space is developing an electromagnetic accelerator for lunar supplies and that a co-founder invested $6 million, which could support a long-duration moon logistics thesis, but the reviewed sources includes no retained direct evidence or article summaries inside the recent evidence window.

Why now: There is no strong why-now signal because coverage data shows zero articles after recent evidence window and zero evidence after recent evidence window; the cited support article is referenced only in membership rationale without a in the reviewed sources.

Caveats: No article is provided for membership support article, so the underlying factual statements cannot be elevated beyond low-confidence context. No direct positive or direct negative evidence are available after recent evidence window. Long-horizon potential exists, but current reviewed sources support is too thin for a stronger score.

Thesis: Article-level context also highlights structural Earth observation monetization difficulty and long procurement cycles, creating real commercialization risk even after the raise.

Why now: Xoople closed a $130 million Series B on April 6, 2026/07 and articles say the capital is for building out its constellation; for a 1 year+ horizon, that financing can enable product and deployment progress, but the same dated coverage warns the market has historically been hard to monetize.

Caveats: Positive support is mostly supporting article context rather than positive evidence. Commercialization warning is article context, not a company-specific deterioration event. No direct customer, backlog, or launch milestone evidence is available.

Thesis: There is no direct adverse evidence in the reviewed sources, so risk is moderate-low and mostly reflects inability to verify current contract progression, funding conversion, or execution status from available evidence (: unavailable in reviewed sources).

Why now: Why now is weak because the reviewed sources' recent evidence review and coverage data show zero available evidence after recent evidence window despite the membership rationale referencing a material contract.

Caveats: No current evidence is provided for Contract claim appears only in membership rationale, not in available direct evidence fields. No recency-confirmed follow-through evidence is available.

Thesis: Aavuus remains early-stage, and the evidence is supporting article context rather than direct positive events; the same article describes only pre-seed funding, which implies execution and scaling risk over a 1 year+ horizon.

Why now: The opportunity is timely because the retained article is dated June 9, 2026 and describes a current financing and product build phase rather than stale background context. That said, recency comes from source date/article date, and evidence grounding is still article-level rather than direct fact/events., June 9, 2026

Caveats: Evidence is weak context and supporting article context, not direct structured positive event evidence. No explicit customer, contract, revenue, or regulatory milestone is cited. Same article appears in multiple rows and is not independent confirmation.

Thesis: Risk is modestly elevated because the reviewed sources' membership rationale describes it as a startup that emerged from stealth and raised only a $4M pre-seed, implying early-stage execution and financing risk, but this is not backed by available dated evidence in the ranking payload.

Why now: There is no available dated evidence in the reviewed sources after recent evidence filtering, so recency-based ranking support is weak.

Caveats: No representative articles or evidence are available after recent evidence filtering for ranking support. The phase2 membership rationale mentions a $4M pre-seed and Star Reacher Network, but the cited supporting articles are not provided with usable article summaries or evidence in these reviewed sources.

Thesis: No direct negative evidence is available; the main risk in this ranking is evidence insufficiency rather than a documented adverse development.

Why now: Why-now support is weak because coverage data shows no evidence after recent evidence window, so the cited lunar contract context cannot be refreshed from available evidence.

Caveats: Phase2 rationale cites, and: but no representative article or evidence are available for direct citation. Coverage data reports articles after recent evidence window = 0 and evidence after recent evidence window = 0. Private-company watch item rather than high-conviction ranked candidate.

Thesis: No direct negative evidence is available. Remaining risk comes from the lack of post-recent evidence window evidence proving contract conversion, revenue realization, or mission execution scale.

Why now: Why now is relatively constructive because a named partnership for on-orbit services can matter over a long strategic horizon, but exact timing and materiality cannot be validated from the reviewed sources because only membership rationale is visible.

Caveats: Membership rationale references article ID: but the reviewed sources provide no or article summary. Relation counts are present in support metadata, but relations are context-only unless separately policy-gated. No direct positive or negative evidence arrays are populated.

Thesis: No material negative evidence is present; risk is mainly execution and evidence-gap risk because current launch timing, deployment success, and monetization are not substantiated by the available reviewed sources evidence (: unavailable in reviewed sources).

Why now: Why now is weak because the reviewed sources references a potentially important constellation expansion but provides no post-recent evidence window available evidence to confirm status or timing.

Caveats: No current evidence is provided for No direct evidence remained after the recent evidence filter. Recency of constellation expansion cannot be validated from reviewed sources fields.

Thesis: Risk is modestly elevated because the membership rationale describes IPO and reusable rocket development ambitions, both of which imply capital intensity and execution risk, but there is no available adverse evidence.

Why now: There is no usable dated evidence available after recent evidence filtering, so the reviewed sources does not provide a clear timing catalyst.

Caveats: The membership rationale references an IPO and Lijian-1 launch activity, but those source articles are not included with ranking-usable details in these reviewed sources.

Thesis: The positive financing evidence is stale relative to the reviewed sources' 90-day recent evidence window. The article is dated February 14, 2026, which the reviewed sources say was dropped by the recent evidence filter, so there is no current-window evidence confirming whether financing momentum, backlog conversion, or product adoption continued

Why now: There is no fresh catalyst inside the 90-day evidence window. The visible article was published on February 14, 2026 and is outside the cutoff date of March 29, 2026, so it is useful as background but weak for recency-sensitive ranking

Caveats: The visible positive article is outside the 90-day recent evidence window cutoff and was dropped from reviewed evidence. External supporting source context is allowed as evidence context but is not merged into primary data source.

Thesis: Risks center on execution and evidence quality rather than explicit adverse news. The financing article carries internal chronology ambiguity because the page was published in 2026 but references a January 19, 2023 financing round, and the overall reviewed sources lack direct negative events, contract-performance data, or milestone completion proof.

Why now: Why now is supported by recent dated context: on June 24, 2026, SpaceNews reported ClearSpace signed an MOU with Shield Space to develop sovereign space defense capabilities for the UK and allies, indicating adjacent market expansion. On May 19, 2026, the company site said it had finalized a EUR 26.7 million Series A and was ramping operations ahead of ClearSpace-1 scheduled to launch in 2026. These dated items fit a 1 year+ horizon because they point to ongoing commercialization and mission preparation.

Caveats: Most evidence is supporting article context, not direct positive events. The financing article published on May 19, 2026 references January 19, 2023 for the Series A round, so funding recency versus page recency should not be conflated.

Thesis: No direct negative evidence is present. Risk remains moderate because the evidence base is only one cited article with no available direct events, leaving uncertainty on commercialization, timeline, and conversion from demonstration activity to durable revenue.

Why now: Why now is the partnership/demo claim referenced in article ID, but the reviewed sources includes neither nor explicit article timing beyond the article ID prefix, limiting recency precision.

Caveats: Opportunity rests on membership rationale rather than fully available direct evidence. Referenced article ID has no in the reviewed sources. Demo activity is not the same as proven commercial traction.

Thesis: Risk is non-trivial because the thesis depends on execution of a global rollout in a capital-intensive reusable space transportation market, but the reviewed sources does not show direct adverse events. Risk is therefore moderate rather than high.

Why now: The key catalyst is recent and explicit: on June 16, 2026 the company announced the Series B close and said the proceeds will finance global rollout and scaling of commercial and operational teams in the US and Europe.

Caveats: Evidence comes from a company-published article, so it is not fully independent. No direct structured positive event row is provided beyond supporting article context.

Thesis: Because the reviewed sources frames the company around surveillance/spy satellite activity rather than commercial traction, and provides no direct positive operating evidence, the name screens as a limited-visibility watchlist with modest evidence-based risk.

Why now: Why now is weak because there are no available post-recent evidence window evidence, no article summaries, and no clear near- or long-horizon catalyst beyond generic association with a surveillance satellite.

Caveats: Membership rationale cites article IDs and, but the reviewed sources provide no. Company is private and evidence coverage inside the recent evidence window is empty.

Thesis: Execution and financing risk remain material because the reviewed sources contain no kept direct evidence on follow-on funding, customer adoption, revenue conversion, or post-demo performance; technology demonstration does not by itself prove scale-up.

Why now: The membership support references articles, and, implying a narrative of funding plus orbital demonstration, but active evidence remains empty after recent evidence filtering, limiting recency confidence.

Caveats: In-orbit demo claim appears only in reviewed sources rationale, not available direct evidence. No evidence confirms whether the prior seed round falls within the current decision horizon relevance. No direct adverse evidence is present, but that is not proof of low fundamental risk.

Thesis: Risk is mostly commercialization uncertainty. The reviewed sources does not provide direct negative evidence, but it also lacks direct available proof of revenue, customer conversion, or broader market adoption.

Why now: Why now is the reviewed sources' claim that the company addresses a key EO data-processing bottleneck and has space-agency support, referenced to article ID: though no or timestamp detail was provided.

Caveats: Claims come from membership rationale rather than direct evidence. Referenced article ID: lacks a reviewed sources. Support from agencies and target users is weaker than demonstrated contracted revenue.

Thesis: The reviewed sources' clearest adverse context is that EON Space Labs was identified as one of the Indian private space companies affected by a PSLV failure, which could create execution, schedule, or financing ripple effects over a 1 year+ horizon, though the underlying article detail is not surfaced in the scoring evidence fields.

Why now: Why now is stronger than for most names here because the phase2 rationale specifically ties EON Space Labs to a PSLV failure context via article: implying a concrete event rather than generic company context. However, conviction remains low because the reviewed sources omits the underlying event summary and dates in the evidence exposed here.

Caveats: The adverse signal appears only in phase2 rationale, not in direct negative evidence. No article summary, quote, or timing detail is provided in the scoring fields. Impact magnitude on EON specifically cannot be quantified from these reviewed sources alone.

Thesis: Risk remains moderate because the reviewed sources offers only one supporting article context and no direct positive event row beyond that summary, leaving unclear whether the satellite is generating revenue, delivering performance, or leading to follow-on orders.

Why now: Why now is the dated first-satellite launch article from May 5, 2026, which is recent within the 90-day recent evidence window and relevant to a long-horizon de-risking story, though still early-stage.

Caveats: Evidence is supporting article context only, not a stronger structured positive event row. Single-article universe limits corroboration. No financing, customer, revenue, or performance follow-through evidence is provided.

Thesis: Execution and commercialization risk remain meaningful because the retained evidence is still mainly company-provided article context and a technology demonstration milestone, not third-party validated contract wins, revenue conversion, or mission success; an undated directory listing that GITAI is 'operating' is weaker context and not recency proof.

Why now: The key catalyst is recent and inside recent evidence window: on June 16, 2026, GITAI announced completion of the S3 flight model for an on-orbit servicing demonstration mission, which is directly relevant to a 1 year+ horizon because it may precede launch, demonstration, and downstream defense/commercial adoption over the next year.

Caveats: Primary evidence is from the company itself. No retained independent customer, contract, or revenue evidence is provided. The spaceindex.io entry is undated and should not be treated as recency proof.

Thesis: The same reviewed sources rationale says Goonhilly is being acquired by Intuitive Machines, which can create integration, ownership, and business-state uncertainty over a 1 year+ horizon. Because no retained dated evidence are available, this risk is only moderately ranked.

Why now: The only 'why now' available is the reviewed sources' statement that Goonhilly is being acquired by Intuitive Machines, cited in phase-2 support, and: but no, timestamps, or retained evidence are provided, so recency and sequence cannot be validated.

Caveats: The reviewed sources rationale states Goonhilly has ground-station/COMSAT revenue and is being acquired by Intuitive Machines, tied to, and: but no or retained evidence are present. Coverage debug still shows articles after recent evidence window = 0 and evidence after recent evidence window = 0. Because chronology cannot be verified, transaction-state claims should be treated cautiously.

Thesis: The reviewed sources does not show material adverse company-specific events; main risk is that most support is financing/context evidence rather than audited operating metrics or margins.

Why now: On June 9, 2026 ICEYE disclosed a €450 million primary Series F at valuation above €10 billion, with total round size above €1 billion including secondary, and later June context also referenced a €300 million revolving credit facility and additional sovereign satellite demand; those are recent business-state signals for a 1 year+ horizon.

Caveats: Some support is supporting article context rather than company-specific positive evidence. Several supporting demand/customer references are undated, so recency is uncertain for those claims.